Search results

Order by most recent / most popular / relevance

Results: 1-10 of 42

Impacts of the Amazon.com decisions on medical use claims in Canada

Gowling Lafleur Henderson LLP
-
Canada
-
July 13 2012

Methods of medical treatment and surgery are not statutory subject matter in Canada

Apotex loses the war in Canada and the battle in England: UK courts rely on Canadian decision to find Apotex acting unlawfully in cCnada has consequences in eErope

Gowling Lafleur Henderson LLP
-
Canada, United Kingdom
-
October 13 2011

Servier developed perindopril erbumine (“perindopril”) which is a successful long lasting ACE inhibitor sold under the trade-mark COVERSYL

An equity partner in a law firm is also an employee for the purposes of employment legislation

Gowling Lafleur Henderson LLP
-
Canada
-
July 31 2011

The British Columbia Supreme Court upheld a Human Rights Tribunal decision that decided that an equity partner in a law firm was also an employee for the purposes of employment legislation

Cojocaru v. British Columbia Women’s Hospital: Trial judges must show independent thought or risk being over turned

Gowling Lafleur Henderson LLP
-
Canada
-
June 8 2011

The British Columbia Court of Appeal rejected a trial decision because the decision below did not appear to be the result of independent and impartial analysis: In Cojocaru (Guardian Ad Litem) v. British Columbia Women’s Hospital and Health Center (2011 BCCA 192), a majority of the British Columbia Court of Appeal ordered a new trial where the judgment of the trial judge consisted of an excessive verbatim re-counting of the successful party’s written submissions

Eli Lilly v Apotex, PMNOC proceedings, strattera, October 29, 2010

Gowling Lafleur Henderson LLP
-
Canada
-
November 24 2010

Eli Lilly sought an order of prohibition against Apotex until expiry of its patent for atomoxetine (the '735 patent

Novopharm v Pfizer, motion for interim relief pending appeal, pregabalin, October 5, 2010

Gowling Lafleur Henderson LLP
-
Canada
-
November 24 2010

See the earlier decisions in this case in the May 2010 and July 2010 editions of this newsletter

Merck v Apotex, PMNOC proceedings, dorzolamide, October 22, 2010

Gowling Lafleur Henderson LLP
-
Canada
-
November 24 2010

This proceeding for an order of prohibition was a companion case to the case described below

Merck v Apotex, PMNOC proceedings, dorzolamide and timolol, October 22, 2010

Gowling Lafleur Henderson LLP
-
Canada
-
November 24 2010

Merck’s patent in this case (the ‘965 patent) covered the co-administration and co-formulation of dorzolamide and timolol (which was sold as COSOPT

Janssen v Mylan, unsuccessful PMNOC proceedings, galantamine, November 11, 2010

Gowling Lafleur Henderson LLP
-
Canada
-
November 24 2010

Janssen sought an order of prohibition until expiry of its '950 patent which claimed the use of an optimum dosing regimen of galantamine to treat Alzheimer's Disease

Hospira v Eli Lilly, appeal of order for further and better production of documents, gemcitabine, October 26, 2010

Gowling Lafleur Henderson LLP
-
Canada
-
November 24 2010

Eli Lilly alleged that gemcitabine made in China and imported into Canada by Hospira infringes Eli Lilly's patent for an intermediate process step in the manufacture of gemcitabine